BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu Y, Liu C, Pang Z. Dendrimer-Based Drug Delivery Systems for Brain Targeting. Biomolecules 2019;9:E790. [PMID: 31783573 DOI: 10.3390/biom9120790] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 12.3] [Reference Citation Analysis]
Number Citing Articles
1 Singh A, Maharana SK, Shukla R, Kesharwani P. Nanotherapeutics approaches for targeting alpha synuclien protein in the management of Parkinson disease. Process Biochemistry 2021;110:181-94. [DOI: 10.1016/j.procbio.2021.08.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sun P, Xiao Y, Di Q, Ma W, Ma X, Wang Q, Chen W. Transferrin Receptor-Targeted PEG-PLA Polymeric Micelles for Chemotherapy Against Glioblastoma Multiforme. Int J Nanomedicine 2020;15:6673-88. [PMID: 32982226 DOI: 10.2147/IJN.S257459] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 Singh V, Sahebkar A, Kesharwani P. Poly (propylene imine) dendrimer as an emerging polymeric nanocarrier for anticancer drug and gene delivery. European Polymer Journal 2021;158:110683. [DOI: 10.1016/j.eurpolymj.2021.110683] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
4 Narayanamurthy R, Yang JJ, Yager JY, Unsworth LD. Drug delivery platforms for neonatal brain injury. J Control Release 2021;330:765-87. [PMID: 33417984 DOI: 10.1016/j.jconrel.2020.12.056] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peña-Juárez MC, Guadarrama-Escobar OR, Escobar-Chávez JJ. Transdermal Delivery Systems for Biomolecules. J Pharm Innov 2021;:1-14. [PMID: 33425065 DOI: 10.1007/s12247-020-09525-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
6 Singh V, Kesharwani P. Dendrimer as a promising nanocarrier for the delivery of doxorubicin as an anticancer therapeutics. J Biomater Sci Polym Ed 2021;:1-28. [PMID: 34078252 DOI: 10.1080/09205063.2021.1938859] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Onyeje C, Lavik E. Highlighting the usage of polymeric nanoparticles for the treatment of traumatic brain injury: A review study. Neurochem Int 2021;147:105048. [PMID: 33901586 DOI: 10.1016/j.neuint.2021.105048] [Reference Citation Analysis]
8 Mignani S, Shi X, Karpus A, Majoral JP. Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs. Eur J Med Chem 2021;209:112905. [PMID: 33069435 DOI: 10.1016/j.ejmech.2020.112905] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
9 Alotaibi BS, Buabeid M, Ibrahim NA, Kharaba ZJ, Ijaz M, Noreen S, Murtaza G. Potential of Nanocarrier-Based Drug Delivery Systems for Brain Targeting: A Current Review of Literature. Int J Nanomedicine 2021;16:7517-33. [PMID: 34795481 DOI: 10.2147/IJN.S333657] [Reference Citation Analysis]
10 Shringarpure M, Gharat S, Momin M, Omri A. Management of epileptic disorders using nanotechnology-based strategies for nose-to-brain drug delivery. Expert Opin Drug Deliv 2021;18:169-85. [PMID: 32921169 DOI: 10.1080/17425247.2021.1823965] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Su S, M Kang P. Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems. Pharmaceutics 2020;12:E837. [PMID: 32882875 DOI: 10.3390/pharmaceutics12090837] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
12 Chen W, Jiang L, Hu Y, Fang G, Yang B, Li J, Liang N, Wu L, Hussain Z. Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review. J Control Release 2021;340:342-60. [PMID: 34695522 DOI: 10.1016/j.jconrel.2021.10.020] [Reference Citation Analysis]
13 Sarma A, Bania R, Devi JR, Deka S. Therapeutic nanostructures and nanotoxicity. J Appl Toxicol 2021;41:1494-517. [PMID: 33641187 DOI: 10.1002/jat.4157] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Liaw K, Zhang F, Mangraviti A, Kannan S, Tyler B, Kannan RM. Dendrimer size effects on the selective brain tumor targeting in orthotopic tumor models upon systemic administration. Bioeng Transl Med 2020;5:e10160. [PMID: 32440565 DOI: 10.1002/btm2.10160] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
15 Patel RB, Rao HR, Thakkar DV, Patel MR. Comprehending the potential of metallic, lipid, and polymer-based nanocarriers for treatment and management of depression. Neurochem Int 2021;153:105259. [PMID: 34942308 DOI: 10.1016/j.neuint.2021.105259] [Reference Citation Analysis]
16 Bai SB, Cheng Y, Liu DZ, Ji QF, Liu M, Zhang BL, Mei QB, Zhou SY. Bone-targeted PAMAM nanoparticle to treat bone metastases of lung cancer. Nanomedicine (Lond) 2020;15:833-49. [PMID: 32163008 DOI: 10.2217/nnm-2020-0024] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
17 Zloh M, Barata TS. An update on the use of molecular modeling in dendrimers design for biomedical applications: are we using its full potential? Expert Opin Drug Discov 2020;15:1015-24. [PMID: 32452244 DOI: 10.1080/17460441.2020.1769597] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Kumar R, Chhikara BS, Gulia K, Chhillar M. Review of nanotheranostics for molecular mechanisms underlying psychiatric disorders and commensurate nanotherapeutics for neuropsychiatry: The mind knockout. Nanotheranostics 2021;5:288-308. [PMID: 33732601 DOI: 10.7150/ntno.49619] [Reference Citation Analysis]
19 Trosheva KS, Sorokina SA, Efimova АА, Semenyuk PI, Berkovich AK, Yaroslavov AA, Shifrina ZB. Interaction of multicomponent anionic liposomes with cationic pyridylphenylene dendrimer: Does the complex behavior depend on the liposome composition? Biochim Biophys Acta Biomembr 2021;1863:183761. [PMID: 34480877 DOI: 10.1016/j.bbamem.2021.183761] [Reference Citation Analysis]
20 Sorokina SA, Shifrina ZB. Dendrimers as Antiamyloid Agents. Pharmaceutics 2022;14:760. [DOI: 10.3390/pharmaceutics14040760] [Reference Citation Analysis]
21 Ramalingam P, Ganesan P, Prabakaran DS, Gupta PK, Jonnalagadda S, Govindarajan K, Vishnu R, Sivalingam K, Sodha S, Choi DK, Ko YT. Lipid Nanoparticles Improve the Uptake of α-Asarone Into the Brain Parenchyma: Formulation, Characterization, In Vivo Pharmacokinetics, and Brain Delivery. AAPS PharmSciTech 2020;21:299. [PMID: 33140227 DOI: 10.1208/s12249-020-01832-8] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Khatoon R, Alam MA, Sharma PK. Current approaches and prospective drug targeting to brain. Journal of Drug Delivery Science and Technology 2021;61:102098. [DOI: 10.1016/j.jddst.2020.102098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Reddy S, Tatiparti K, Sau S, Iyer AK. Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors. Drug Discov Today 2021;26:1944-52. [PMID: 33865978 DOI: 10.1016/j.drudis.2021.04.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
24 Akel H, Ismail R, Katona G, Sabir F, Ambrus R, Csóka I. A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation. Int J Pharm 2021;604:120724. [PMID: 34023443 DOI: 10.1016/j.ijpharm.2021.120724] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Anik MI, Hossain MK, Hossain I, Mahfuz AMUB, Rahman MT, Ahmed I. Recent progress of magnetic nanoparticles in biomedical applications: A review. Nano Select 2021;2:1146-86. [DOI: 10.1002/nano.202000162] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
26 Moin A, Rizvi SMD, Hussain T, Gowda DV, Subaiea GM, Elsayed MMA, Ansari M, Alanazi AS, Yadav H. Current Status of Brain Tumor in the Kingdom of Saudi Arabia and Application of Nanobiotechnology for Its Treatment: A Comprehensive Review. Life (Basel) 2021;11:421. [PMID: 34063122 DOI: 10.3390/life11050421] [Reference Citation Analysis]
27 Acter S, Vidallon MLP, Crawford S, Tabor RF, Teo BM. Bowl-Shaped Mesoporous Polydopamine Nanoparticles for Size-Dependent Endocytosis into HeLa Cells. ACS Appl Nano Mater 2021;4:9536-46. [DOI: 10.1021/acsanm.1c01897] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
28 Latour M, Her NG, Kesari S, Nurmemmedov E. WNT Signaling as a Therapeutic Target for Glioblastoma. Int J Mol Sci 2021;22:8428. [PMID: 34445128 DOI: 10.3390/ijms22168428] [Reference Citation Analysis]
29 Arredondo-ochoa T, Silva-martínez GA. Microemulsion Based Nanostructures for Drug Delivery. Front Nanotechnol 2022;3:753947. [DOI: 10.3389/fnano.2021.753947] [Reference Citation Analysis]
30 Ayub A, Wettig S. An Overview of Nanotechnologies for Drug Delivery to the Brain. Pharmaceutics 2022;14:224. [DOI: 10.3390/pharmaceutics14020224] [Reference Citation Analysis]
31 Sola P, Krishnamurthy P, Chintamaneni PK, Pindiprolu SKS, Kumari M. Novel drug delivery systems of β2 adrenoreceptor agonists to suppress SNCA gene expression and mitochondrial oxidative stress in Parkinson’s disease management. Expert Opinion on Drug Delivery 2020;17:1119-32. [DOI: 10.1080/17425247.2020.1779218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
32 Eshraghi M, Ahmadi M, Afshar S, Lorzadeh S, Adlimoghaddam A, Rezvani Jalal N, West R, Dastghaib S, Igder S, Torshizi SRN, Mahmoodzadeh A, Mokarram P, Madrakian T, Albensi BC, Łos MJ, Ghavami S, Pecic S. Enhancing autophagy in Alzheimer's disease through drug repositioning. Pharmacol Ther 2022;237:108171. [PMID: 35304223 DOI: 10.1016/j.pharmthera.2022.108171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Liu Z, Ji X, He D, Zhang R, Liu Q, Xin T. Nanoscale Drug Delivery Systems in Glioblastoma. Nanoscale Res Lett 2022;17:27. [PMID: 35171358 DOI: 10.1186/s11671-022-03668-6] [Reference Citation Analysis]
34 Torabi Fard N, Tadayon F, Ahmad Panahi H, Moniri E. The synthesis of functionalized graphene oxide by polyester dendrimer as a pH-sensitive nanocarrier for targeted delivery of venlafaxine hydrochloride: Central composite design optimization. Journal of Molecular Liquids 2022;349:118149. [DOI: 10.1016/j.molliq.2021.118149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Shetty A, Chikhaliwala P, Suryawanshi J, Chandra S. Understanding Physico-chemical Interactions of Dendrimers with Guest Molecules for Efficient Drug and Gene Delivery. Curr Pathobiol Rep 2021;9:57-70. [DOI: 10.1007/s40139-021-00221-5] [Reference Citation Analysis]
36 Moorthy H, Govindaraju T. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine. ACS Appl Bio Mater 2021;4:1115-39. [PMID: 35014470 DOI: 10.1021/acsabm.0c01319] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 12.0] [Reference Citation Analysis]
37 Dąbkowska M, Ulańczyk Z, Łuczkowska K, Rogińska D, Sobuś A, Wasilewska M, Olszewska M, Jakubowska K, Machaliński B. The role of the electrokinetic charge of neurotrophis-based nanocarriers: protein distribution, toxicity, and oxidative stress in in vitro setting. J Nanobiotechnology 2021;19:258. [PMID: 34454520 DOI: 10.1186/s12951-021-00984-4] [Reference Citation Analysis]
38 Riccardi C, Napolitano F, Montesarchio D, Sampaolo S, Melone MAB. Nanoparticle-Guided Brain Drug Delivery: Expanding the Therapeutic Approach to Neurodegenerative Diseases. Pharmaceutics 2021;13:1897. [PMID: 34834311 DOI: 10.3390/pharmaceutics13111897] [Reference Citation Analysis]
39 Li B, Ge L, Lyu P, Chen M, Zhang X, Xie S, Wu Q, Kwok HF. Handheld pH meter-assisted immunoassay for C-reactive protein using glucose oxidase-conjugated dendrimer loaded with platinum nanozymes. Mikrochim Acta 2021;188:14. [PMID: 33389237 DOI: 10.1007/s00604-020-04687-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
40 Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges. Adv Sci (Weinh) 2021;8:2003937. [PMID: 34026447 DOI: 10.1002/advs.202003937] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 19.0] [Reference Citation Analysis]
41 Das SS, Bharadwaj P, Bilal M, Barani M, Rahdar A, Taboada P, Bungau S, Kyzas GZ. Stimuli-Responsive Polymeric Nanocarriers for Drug Delivery, Imaging, and Theragnosis. Polymers (Basel) 2020;12:E1397. [PMID: 32580366 DOI: 10.3390/polym12061397] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 33.5] [Reference Citation Analysis]
42 Arango D, Bittar A, Esmeral NP, Ocasión C, Muñoz-Camargo C, Cruz JC, Reyes LH, Bloch NI. Understanding the Potential of Genome Editing in Parkinson's Disease. Int J Mol Sci 2021;22:9241. [PMID: 34502143 DOI: 10.3390/ijms22179241] [Reference Citation Analysis]